School of Medicine, Jinan University, Guangzhou, China.
Department of Infectious Diseases and Public Health, City University of Hong Kong, Hong Kong, China.
JMIR Public Health Surveill. 2022 Aug 16;8(8):e37422. doi: 10.2196/37422.
China and the United States play critical leading roles in the global effort to contain the COVID-19 virus. Therefore, their population's preferences for initial diagnosis were compared to provide policy and clinical insights.
We aim to quantify and compare the public's preferences for medical management of fever and the attributes of initial diagnosis in the case of presenting symptoms during the COVID-19 pandemic in China and the United States.
We conducted a cross-sectional study from January to March 2021 in China and the United States using an online discrete choice experiment (DCE) questionnaire distributed through Amazon Mechanical Turk (MTurk; in the United States) and recruited volunteers (in China). Propensity score matching (PSM) was used to match the 2 groups of respondents from China and the United States to minimize confounding effects. In addition, the respondents' preferences for different diagnosis options were evaluated using a mixed logit model (MXL) and latent class models (LCMs). Moreover, demographic data were collected and compared using the chi-square test, Fisher test, and Mann-Whitney U test.
A total of 9112 respondents (5411, 59.4%, from China and 3701, 40.6%, from the United States) who completed our survey were included in our analysis. After PSM, 1240 (22.9%) respondents from China and 1240 (33.5%) from the United States were matched for sex, age, educational level, occupation, and annual salary levels. The segmented sizes of 3 classes of respondents from China were 870 (70.2%), 270 (21.8%), and 100 (8.0%), respectively. Meanwhile, the US respondents' segmented sizes were 269 (21.7%), 139 (11.2%), and 832 (67.1%), respectively. Respondents from China attached the greatest importance to the type of medical institution (weighted importance=40.0%), while those from the United States valued the waiting time (weighted importance=31.5%) the most. Respondents from China preferred the emergency department (coefficient=0.973, reference level: online consultation) and fever clinic (a special clinic for the treatment of fever patients for the prevention and control of acute infectious diseases in China; coefficient=0.974, reference level: online consultation), while those from the United States preferred private clinics (general practices; coefficient=0.543, reference level: online consultation). Additionally, shorter waiting times, COVID-19 nucleic acid testing arrangements, higher reimbursement rates, and lower costs were always preferred.
Improvements in the availability of COVID-19 testing and medical professional skills and increased designated health care facilities may help boost potential health care seeking during COVID-19 and prevent unrecognized community spreading of SARS-CoV-2 in China and the United States. Moreover, to better prevent future waves of pandemics, identify undiagnosed patients, and encourage those undiagnosed to seek health care services to curb the pandemic, the hierarchical diagnosis and treatment system needs improvement in China, and the United States should focus on reducing diagnosis costs and raising the reimbursement rate of medical insurance.
中国和美国在遏制 COVID-19 病毒的全球努力中发挥着关键的领导作用。因此,比较了两国民众对初始诊断的偏好,以提供政策和临床见解。
我们旨在量化和比较中国和美国在 COVID-19 大流行期间出现症状时,公众对发热医疗管理和初始诊断属性的偏好。
我们于 2021 年 1 月至 3 月在中国和美国进行了一项横断面研究,使用在线离散选择实验(DCE)问卷通过亚马逊 Mechanical Turk(MTurk;在美国)和志愿者招募(在中国)进行分发。使用倾向评分匹配(PSM)将来自中国和美国的两组受访者进行匹配,以尽量减少混杂效应。此外,使用混合 logit 模型(MXL)和潜在类别模型(LCMs)评估受访者对不同诊断选择的偏好。此外,收集并使用卡方检验、Fisher 检验和 Mann-Whitney U 检验比较人口统计学数据。
共有 9112 名受访者(中国 5411 名,占 59.4%,美国 3701 名,占 40.6%)完成了我们的调查,纳入了我们的分析。经过 PSM 后,中国有 1240 名(22.9%)受访者和美国有 1240 名(33.5%)受访者在性别、年龄、教育程度、职业和年薪水平上相匹配。中国受访者的分段大小分别为 870(70.2%)、270(21.8%)和 100(8.0%)。同时,美国受访者的分段大小分别为 269(21.7%)、139(11.2%)和 832(67.1%)。中国受访者最重视医疗机构类型(加权重要性=40.0%),而美国受访者最看重等待时间(加权重要性=31.5%)。中国受访者更喜欢急诊部(系数=0.973,参考水平:在线咨询)和发热门诊(中国用于预防和控制急性传染病的专门发热患者治疗的发热门诊;系数=0.974,参考水平:在线咨询),而美国受访者更喜欢私人诊所(普通科医生;系数=0.543,参考水平:在线咨询)。此外,较短的等待时间、COVID-19 核酸检测安排、更高的报销率和更低的成本总是更受欢迎。
提高 COVID-19 检测和医疗专业技能的可及性,并增加指定的医疗保健设施,可能有助于促进 COVID-19 期间潜在的医疗保健寻求,并防止 SARS-CoV-2 在中美两国社区中未被发现的传播。此外,为了更好地预防未来的疫情浪潮,发现未确诊的患者,并鼓励未确诊的患者寻求医疗服务以遏制大流行,中国需要改进分级诊疗体系,美国应重点降低诊断成本并提高医疗保险报销率。